Celltrion Pharm, Inc. (KOSDAQ:068760)

South Korea flag South Korea · Delayed Price · Currency is KRW
57,900
0.00 (0.00%)
Apr 28, 2026, 3:30 PM KST
21.77%
Market Cap 2.56T
Revenue (ttm) 274.73B
Net Income (ttm) 26.03B
Shares Out 44.21M
EPS (ttm) 583.36
PE Ratio 99.25
Forward PE n/a
Dividend 200.00 (0.34%)
Ex-Dividend Date Dec 29, 2025
Volume 86,704
Average Volume 68,744
Open 58,000
Previous Close 57,900
Day's Range 57,600 - 58,500
52-Week Range 44,902 - 78,300
Beta 1.18
RSI 48.76
Earnings Date n/a

About Celltrion Pharm

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operat... [Read more]

Sector Healthcare
Founded 1976
Employees 328
Stock Exchange KOSDAQ
Ticker Symbol 068760
Full Company Profile

Financial Performance

In 2020, Celltrion Pharm's revenue was 233.57 billion, an increase of 34.61% compared to the previous year's 173.51 billion. Earnings were 20.94 billion, an increase of 143.42%.

Financial Statements

News

There is no news available yet.